shared neoantigen
Showing 1 - 25 of 1,203
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
A Study of Personalized Neoantigen Cancer Vaccines
Completed
- Non Small Cell Lung Cancer
- +4 more
- Blood collection for research (next-generation sequencing [NGS])
- Blood collection for research (HLA typing)
-
Chicago, Illinois
- +4 more
Sep 10, 2020
Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA
Not yet recruiting
- Adrenal Cortical Carcinoma
- +3 more
- individualized mRNA neoantigen vaccine (mRNA-0523-L001)
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023
Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)
Recruiting
- Melanoma
- Metastatic Melanoma
- CDX-301
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 12, 2023
Ovarian Cancer Trial in Boston (drug, biological, procedure)
Recruiting
- Ovarian Cancer
- Nivolumab
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 11, 2022
Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA
Recruiting
- Lynch Syndrome
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
- +2 more
-
Duarte, California
- +3 more
Nov 22, 2022
Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)
Not yet recruiting
- Advanced Malignant Solid Tumors
- Neoantigen peptide vaccine
- Neoantigen-based DC immune preparation
-
Nanchang, Jiangxi, ChinaFirst Affiliated Hospital of Nanchang University
Mar 1, 2023
Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,
Recruiting
- Endocrine/Neuroendocrine
- +4 more
- Fludarabine
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)
Enrolling by invitation
- Cancer
- Solid Tumor
- Personalized Synthetic Long Peptide Vaccine
-
San Francisco, CaliforniaQuest Clinical Research
Feb 20, 2023
Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Optimized neoantigen synthetic long peptide
Recruiting
- Pancreas Cancer
- +2 more
- Optimized neoantigen synthetic long peptide vaccine
- Poly-ICLC
-
Saint Louis, MissouriWashington University School of Medicine
Jan 23, 2023
Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation
Not yet recruiting
- Unmethylated Glioblastoma
- Personalized Neoantigen DNA vaccine
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 14, 2023
Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)
Not yet recruiting
- Myelofibrosis
- +2 more
- Peptide-based vaccine
- Poly ICLC
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 7, 2022
Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)
Completed
- Metastatic Hormone-Sensitive Prostate Cancer
- PROSTVAC-V
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 3, 2022
Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)
Not yet recruiting
- Pancreatic Cancer
- Adebrelimab
- mRNA tumor vaccines
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023
NSCLC, EGFR Gene Mutation Trial in Nanjing (neo-antigen vaccine)
Recruiting
- NSCLC
- EGFR Gene Mutation
- neo-antigen vaccine
-
Nanjing, ChinaThe Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,
Oct 19, 2023
Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)
Not yet recruiting
- Glioblastoma Multiforme of Brain
- TVI-Brain-1
- +3 more
- (no location specified)
Jan 13, 2023
Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (biological, drug, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- Neoantigen Peptide Vaccine
- +2 more
-
Baltimore, Maryland
- +1 more
Mar 15, 2022
Pancreatic Tumor Trial in Shanghai (Personalized neoantigen vaccine)
Recruiting
- Pancreatic Tumor
- Personalized neoantigen vaccine
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 8, 2022
Triple Negative Breast Cancer, Triple Negative Breast Tumors, TNBC - Triple-Negative Breast Cancer Trial in Saint Louis (drug,
Active, not recruiting
- Triple Negative Breast Cancer
- +3 more
- Durvalumab
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Mar 14, 2022
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Durvalumab
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 26, 2023
Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)
Not yet recruiting
- Advanced Malignant Solid Tumors
- Neoantigen mRNA Personalised Cancer vaccine
- (no location specified)
Jul 16, 2023
Kidney Cancer Trial in Boston (NeoVax, Ipilimumab)
Recruiting
- Kidney Cancer
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 22, 2022
Smoldering Plasma Cell Myeloma Trial in Houston (procedure, drug, biological)
Recruiting
- Smoldering Plasma Cell Myeloma
- Biopsy Specimen Radiography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 12, 2021